UvA Ventures Holding
11
53K
11
2
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Amsterdam. The company was established in Europe in The Netherlands.
Among the most popular fund investment industries, there are Medical Device, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Photanol. For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands.
The high activity for fund was in 2008. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Life Sciences Fund Amsterdam, PPM Oost NV, NLC - The Healthtech Venture Builder.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 2
- Investments by industry
- Biotechnology (5)
- Health Care (2)
- Computer Vision (2)
- Artificial Intelligence (2)
- Machine Learning (2) Show 17 more
- Investments by region
-
- Netherlands (10)
- The Netherlands (1)
- Peak activity year
- 2008
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Anywyse | 11 May 2023 | E-Learning, EdTech, Education, Audio, Podcast | Seed | Noord-Holland, Amsterdam, The Netherlands | |
| EpiCept Corporation | 01 Jan 2000 | Information Technology | Early Stage Venture | 4M | United States, New Jersey |
| Photanol | 01 Mar 2008 | Biotechnology, Renewable Energy, Chemical | Seed | 0 | Amsterdam, Netherlands, North Holland |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.